Danaher Co. (NYSE:DHR) Shares Bought by Full Sail Capital LLC

Full Sail Capital LLC grew its position in Danaher Co. (NYSE:DHR) by 2.5% during the 4th quarter, HoldingsChannel.com reports. The fund owned 2,730 shares of the conglomerate’s stock after buying an additional 66 shares during the quarter. Full Sail Capital LLC’s holdings in Danaher were worth $627,000 at the end of the most recent reporting period.

A number of other large investors have also modified their holdings of DHR. First Hawaiian Bank raised its stake in Danaher by 10.9% during the fourth quarter. First Hawaiian Bank now owns 5,220 shares of the conglomerate’s stock worth $1,198,000 after purchasing an additional 512 shares during the period. Hudson Valley Investment Advisors Inc. ADV grew its stake in Danaher by 1.9% during the 4th quarter. Hudson Valley Investment Advisors Inc. ADV now owns 47,003 shares of the conglomerate’s stock worth $10,790,000 after purchasing an additional 897 shares in the last quarter. ORG Partners LLC increased its stake in shares of Danaher by 1,212.8% during the fourth quarter. ORG Partners LLC now owns 2,770 shares of the conglomerate’s stock worth $636,000 after buying an additional 2,559 shares during the period. Wealth Enhancement Advisory Services LLC increased its position in shares of Danaher by 0.3% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 199,493 shares of the conglomerate’s stock valued at $45,794,000 after purchasing an additional 591 shares during the last quarter. Finally, ST Germain D J Co. Inc. raised its stake in Danaher by 13.9% in the fourth quarter. ST Germain D J Co. Inc. now owns 3,558 shares of the conglomerate’s stock valued at $817,000 after buying an additional 433 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

Several research analysts have recently issued reports on the stock. Citigroup restated a “buy” rating on shares of Danaher in a report on Monday, April 7th. Guggenheim reissued a “buy” rating and issued a $250.00 target price on shares of Danaher in a report on Wednesday, April 23rd. Wells Fargo & Company lowered their price objective on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research note on Thursday, January 30th. Jefferies Financial Group cut their price objective on shares of Danaher from $260.00 to $230.00 and set a “buy” rating for the company in a research report on Tuesday, April 22nd. Finally, Stifel Nicolaus raised shares of Danaher from a “hold” rating to a “buy” rating and set a $260.00 price target for the company in a research report on Friday, March 14th. Five analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $264.40.

Insider Buying and Selling

In related news, EVP Christopher Paul Riley sold 15,805 shares of the company’s stock in a transaction dated Wednesday, April 30th. The shares were sold at an average price of $198.00, for a total value of $3,129,390.00. Following the completion of the sale, the executive vice president now owns 15,179 shares of the company’s stock, valued at $3,005,442. This represents a 51.01 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Corporate insiders own 11.10% of the company’s stock.

Danaher Price Performance

Shares of NYSE DHR opened at $189.42 on Friday. The company has a debt-to-equity ratio of 0.31, a current ratio of 1.40 and a quick ratio of 1.05. The firm has a market capitalization of $135.56 billion, a PE ratio of 35.88, a P/E/G ratio of 2.66 and a beta of 0.80. Danaher Co. has a 1-year low of $171.00 and a 1-year high of $281.70. The business’s fifty day moving average price is $198.39 and its two-hundred day moving average price is $219.46.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, April 22nd. The conglomerate reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.62 by $0.26. The business had revenue of $5.74 billion for the quarter, compared to analysts’ expectations of $5.58 billion. Danaher had a net margin of 16.33% and a return on equity of 10.82%. On average, research analysts expect that Danaher Co. will post 7.63 EPS for the current year.

Danaher Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Stockholders of record on Friday, June 27th will be given a dividend of $0.32 per share. This represents a $1.28 annualized dividend and a dividend yield of 0.68%. Danaher’s dividend payout ratio is presently 24.85%.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.